Covid-19 Impact on Global Human Microbiome Sequencing Market Size, Status and Forecast 2020-2026

Market Analysis and Insights: Global Human Microbiome Sequencing Market
Prior to COVID-19, the market for Human Microbiome Sequencing was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Human Microbiome Sequencing is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Human Microbiome Sequencing market.

Global Human Microbiome Sequencing Scope and Market Size
Human Microbiome Sequencing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Microbiome Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Microbiome Sequencing market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Human Microbiome Sequencing industry.

The key players covered in this study

Baseclear B.V.
Beijing Genomics Institute (BGI) Genomics Co., Ltd
Charles River Laboratories International Inc.
Clinical Microbiomics A/S
Eurofins Scientific SE
GENEWIZ, Inc.
Illumina, Inc.
Novogene Corporation
OraSure Technologies, Inc.
Oxford Nanopore Technologies, Inc.
Pacific Biosciences of California, Inc.
QIAGEN N.V.
Second Genome, Inc.
Thermo Fisher Scientific Inc.
Viome, Inc.
CosmosID
Leucine Rich Bio Pvt. Ltd.
Microba
Microbiome Insights Inc.
Molzym GmbH & Co. KG

Market segment by Type, the product can be split into

Next-Generation Sequencing
Traditional Sequencing Technologies
Other

Market segment by Application, split into

Genome Analysis
Metabolome Analysis
Transcriptome Analysis
Other Omics Analysis

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Human Microbiome Sequencing status, future forecast, growth opportunity, key market and key players.
To present the Human Microbiome Sequencing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Human Microbiome Sequencing are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026

Frequently Asked Questions